For more information about sparsentan’s full approval, please visit: https://ir.travere.com/news-releases/news-release-details/travere-therapeutics-announces-full-fda-approval-filsparir

For more information on Travere’s science and innovation in rare diseases, please visit: https://medicalaffairs.travere.com